Gray Forum
CHAPTER 2 EXECUTIVE SUMMARY

 
Nieuw onderwerp plaatsen   Reageren    Gray Forum // Voorbeeld Forum
Vorige onderwerp :: Volgende onderwerp  
Auteur Bericht
DMT



Geregistreerd op: 08 Mei 2018
Berichten: 422

BerichtGeplaatst: 23-09-2019 10:29:29    Onderwerp: CHAPTER 2 EXECUTIVE SUMMARY Reageren met citaat
Global BiosimilarsFollow-on-Biologics Market 2016: Industry Analysis Cheap Mathieu Perreault Hat , Market Size, Share, Growth an Marketing Articles | June 9, 2016

Intense Research releases a new market research report "World BiosimilarsFollow-on-Biologics Market - Opportunities and Forecasts Cheap Kyle Connor Hat , 2014 - 2020" to add to its collection of research reports.



Biosimilars or follow-on-biologics are highly similar versions of reference biologics derived from living organisms such as plants and animals. The development of biosimilars and validation with reference biologics play a significant role in the commercialization of biosimilars. Economic pricing of biosimilars, ease in development and a quick approval process are some key driving factors that drive the growth of this market. Effective and timely formulated regulations facilitate the viability and balance between original and biosimilar products. Moreover, a favorable regulatory environment and the establishment of IPR protections are factors that boost the market growth. The upcoming patent expiration for blockbuster drugs has revolutionized the aspect of commercialization whilst triggering a large scale adoption of biosimilars. Biosimilars industry is facing problems relating to production efficiency and quantity. The lack of economies of scale for small scale manufacturers and absence of regulatory guidelines in lucrative regions such as China, US are hindering the growth of biosimilars market. However Cheap Mark Scheifele Hat , strong government initiatives pertaining to production and approval is a key factor that would eventually reduce the impact of these restraints over the forecast period. Global biosimilarsfollow-on-biologics market accounted for an overall revenue of $2,552.0 million in 2014 and it is estimated to generate an approximate revenue of $26,551.3 million by 2020, registering a CAGR of 49.1% from 2015 to 2020.


Get Free Sample Report of Biosimilars or follow-on-biologics Market: http:www.intenseresearchmarket-analysisworld-biosimilarsfollow-on-biologics-market-opportunities-and-forecasts#request-sample


The product segment in the biosimilars market comprises of Human Growth Hormone Cheap Josh Morrissey Hat , Erythropoietin, Monoclonal Antibodies, Insulin, Interferon Cheap Joel Armia Hat , Colony Stimulating Factors and others. Biosimilars erythropoietin is the highest revenue generating biosimilars drug candidate owing to its high approval rate for commercialization. Interferon biosimilars are the fastest growing drugs in the biosimilars market. This growth is supplemented by the use of interferon biosimilars across a wide range of applications.


The biosimilars applications market is segmented into blood disorders, oncology diseases, chronic and autoimmune diseases and growth hormone deficiency. The application of biosimilars in blood disease treatment is the highest revenue generating segment owing to the high-priced reference biologics and frequent application. However, biosimilars applications in autoimmune and chronic diseases exhibit the highest potential due to the changing off patent scenario.


Based on geography Cheap Connor Hellebuyck Hat , the biosimilars market is segmented across North America, Europe, Asia-Pacific and LAMEA. Asia Pacific and LAMEA exhibit a large scale demand for biosimilars due to the growing prevalence of chronic diseases in these regions. Collaboration with local players is a key opportunity for biosimilars in developing economies. Many companies such as, Amgen and Novartis are collaborating with Asian players to reach to the depth of the biopharmaceutical market. The absence of effective regulatory guidelines for product approval and commercialization limit the growth of the biosimilars market in North America. However Cheap Michael Hutchinson Hat , recent draft published by US FDA has approved first biosimilar in United States. This would eventually standardized the procedure of approval and commercialization of biosimilars in United States.


This report provides a comprehensive market share analysis of leading companies and highlights the competition in the market. Product launch is the key strategy adopted by the leading player of biosimilars industry. The key companies profiled in this report are Novartis (Sandoz), Synthon Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd. Cheap Dustin Byfuglien Hat , LG Life Sciences, Celltrion, Biocon, Hospira Cheap Nikolaj Ehlers Hat , Merck Serono (Merck Group), Biogen idec, Inc., and Genentech (Roche Group).


Get Full Table Of Content (Index) Of Biosimilars or follow-on-biologics Market: http:www.intenseresearchmarket-analysisworld-biosimilarsfollow-on-biologics-market-opportunities-and-forecasts#table-of-content

Table Of Content Of Biosimilars or follow-on-biologics Market:


Table of Content


CHAPTER 1 INTRODUCTION
1.1 Key Benefits
1.2 Key Market Segment
1.3 Research Methodology
1.3.1 Primary Research
1.3.2 Secondary Research
1.3.3 Analyst tools and models


CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond: what to expect by 2025
2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario


CHAPTER 3 MARKET OVERVIEW
3.1 Market Definition
3.2 Diverse approach of global regulators towards biosimilars
3.3 Safety issues of biosimilar drugs
3.4 Key Findings
3.4.1 Top impacting factors
3.4.2 Top winning strategies
3.4.3 Top investment pockets
3.5 Regulation and Reimbursement scenario
3.5.1 Regulations in United States
3.5.2 Regulations in Europe
3.5.3 Regulation in Asia
3.5.4 Comparison of Biosimilar medicine guidelines
3.6 Emerging economies a hotspot for biosimilars market
3.6.1 Brazil a treasure for the biosimilar manufacturers
3.6.2 China the bulkmarket for biosimilars
3.6.3 India an early adopter of biosimilars


About In Die Attach Materials Marke. Cheap Jerseys Cheap Jerseys Wholesale Jerseys China Wholesale NFL Jerseys Wholesale Hockey Jerseys Wholesale NFL Jerseys Cheap MLB Jerseys Cheap Nike Shoes Womens Wholesale Jordan Shoes 2018 Wholesale Air Max White
Terug naar boven
Profiel bekijken Stuur privébericht
Nieuw onderwerp plaatsen   Reageren    Gray Forum // Voorbeeld Forum Tijden zijn in GMT + 1 uur
Pagina 1 van 1

 
Ga naar:  
Je mag geen nieuwe onderwerpen plaatsen in dit subforum
Je mag geen reacties plaatsen in dit subforum
Je mag je berichten niet bewerken in dit subforum
Je mag je berichten niet verwijderen in dit subforum
Je mag niet stemmen in polls in dit subforum


Wilt u geen reclame op dit forum en genieten van extra voordelen? Klik dan vlug hier voor meer informatie!
 
Powered by phpBB and Andrew Charron
immo op Realo
Maak snel, eenvoudig en gratis uw eigen forum: Gratis Forum